论文部分内容阅读
对1976—79年4年间71例住院肺结核的临床化疗效果进行统计分析。其中54例属初治,17例为复治,均属Ⅲ型。分别采用以下5种方案进行为期三个月的短程强化治疗:(1)第一线药物 SM+INH+PAS,19人;(2)RFP+SM+INH,10人;(3)EMB+SM+INH,14人;(4)RFP+EMB+INH+SM,18人;(5)RFP+EMB+INH,10人。治疗三个月后,(1)～(5)组痰菌阴转率分别为74%、9/10、93%、83%和9/10;平均转阴日数分别为65.1、41.1、27.5、41.8和24.0天,经统计学处理,第一
The clinical chemotherapeutic effect of 71 hospitalized tuberculosis patients during 1976 to 1979 was analyzed statistically. Among them, 54 cases were newly diagnosed and 17 cases were retreatment, all of which belonged to type Ⅲ. (1) first-line drug SM + INH + PAS, 19 people; (2) RFP + SM + INH, 10 people; (3) EMB + SM + INH, 14 people; (4) RFP + EMB + INH + SM, 18 people; (5) RFP + EMB + INH, 10 people. After three months of treatment, the sputum negative conversion rates were 74%, 9/10, 93%, 83% and 9/10 respectively in the groups (1) to (5); the mean days of negative conversion were 65.1, 41.1 and 27.5, 41.8 and 24.0 days, the statistical processing, the first